Healthcare Pharmaceutical Biotech

As Consumers Get Smarter About Supplements, Nutriessential Sets the Benchmark

June 24, 2026 8:00 AM

Nutriessential, a US-based dietary supplement provider, has spent nearly two decades refining its business model that prioritises providing evidence-based dietary supplements to global customers for scientific accountability and implementing a drop-shipping model to ensure biochemical integrity and potency preservation. The company is bypassing recent business trends where speed, pricing, and volume often dictate business decisions. Quality and...

Read more

AQP One Introduces BioBaseline(TM) as a Foundational Standard for Physiological Intelligence

June 24, 2026 3:00 AM

AQP One, Inc., a U.S.-based health technology company, today announced the formal introduction of BioBaseline™, a proprietary physiological modeling framework designed to serve as a foundational standard within its expanding JBA AICare™ Physiological Intelligence Platform. The announcement follows the company's recent expansion of JBA AICare™ into metabolic and GLP-1 trend intelligence, and marks the next step in AQP One's strategy to build an...

Read more

Andes Health Mart Pharmacy Honored as IPC's 2026 Most Valuable Pharmacy

June 24, 2026 1:00 AM

Independent Pharmacy Cooperative (IPC) is proud to announce Andes Health Mart Pharmacy of Effingham, IL, as the recipient of the Dan Moudry Most Valuable Pharmacy (MVP) Award for 2026. The prestigious award was presented to Chip Andes at the IPC Annual Business Meeting on June 19, during McKesson ideaShare 2026 in Denver, CO. Chip Andes has spent decades building Andy's Health Mart Pharmacy into a cornerstone of care in his community, navigating...

Read more

AI medical conference returns to Miami July 10-12

June 23, 2026 9:25 PM

For more than seven years, Boss Doctors has championed physician leadership in healthcare technology, entrepreneurship, and industry transformation. The annual conference serves as a platform where healthcare professionals gain practical strategies for expanding their influence and creating opportunities beyond clinical practice. This year's theme, "Educate, Innovate, and Invest with AI", highlights the organization's mission to equip physicians...

Read more

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010

June 23, 2026 6:00 PM

Onco-Innovations Limited (NEO:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has entered into a services agreement with Nanosoft Polymers ("Nanosoft"), a specialized polymer engineering and drug delivery company, to support the continued development of ONC010, the Company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase ("PNKP") inhibitor. Under the agreement, Nanosoft will...

Read more

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

June 23, 2026 5:20 PM

BioNxt Solutions Inc. (CSNX:BNXT)(OTCQB:BNXTF)(FSE:BXT) (the "Company" or "BioNxt") is pleased to announce that it has closed its previously announced non-brokered private placement (the "LIFEOffering") of units of the Company ("Units") pursuant to the Listed Issuer Financing exemption available under Part 5A of National Instrument 45-106 - Prospectus Exemptions. Pursuant to the LIFE Offering, the Company issued an aggregate of 6,060,606 Units...

Read more

HeroMD 4-MAX Reviews and Complaints 2026: Legit Compounded ED Prescription or Hype? Apomorphine Explained, the No-Refund Rule, and What to Verify Before Enrolling

June 23, 2026 5:10 PM

Title Reference Notice: Promotional phrases used in the title above - including "10X Faster" and "6X Longer" - reflect marketing language and product positioning published by the HeroMD brand on the official product website at heromd.us/ed/4-max. This publication uses these phrases to identify the product and its category positioning to readers arriving from brand advertising; this publication does not independently substantiate, verify, or...

Read more

Desert Oasis Healthcare Home Health Clinical Manager Honored with Prestigious Home Health Leadership Award

June 23, 2026 12:40 PM

Desert Oasis Healthcare (DOHC) is proud to announce that Candice Longshore, RN, Clinical Manager for Desert Oasis Healthcare Home Health, has been selected as the recipient of the Lillian H. O'Brien Supervisor Home Health Award, recognizing her outstanding leadership, clinical excellence, and unwavering commitment to compassionate patient care. The award will be presented during a special ceremony on June 23, 2026, at The Westin Rancho Mirage...

Read more

The Assistance Fund Announces Partnership With JCPenney

June 23, 2026 12:00 PM

The Assistance Fund (TAF), an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced a national partnership with JCPenney that will provide members of the TAF community with exclusive savings on apparel, home goods, accessories, and more. Through the partnership, patients receive an exclusive online and in-store coupon that provides a deep discount and...

Read more

NX Development Corp. Celebrates One-Year Anniversary of Gleolan(R) Commercial Control With Record-Breaking Sales

June 23, 2026 11:00 AM

NX Development Corp. recently celebrated the one-year anniversary of Gleolan's return to our commercial control and we would like to take this opportunity to thank our loyal customers for their continued support. We are proud to report that Gleolan has achieved record-breaking unit sales along with significant growth in our customer base over the past year, both of which are a testament to the clinical value of Gleolan and the trust our...

Read more

Bio-Based Solvents Take Center Stage at CHEMUK

June 23, 2026 11:00 AM

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, took center stage at CHEMUK 2026 with the launch of its first bio-based solvent portfolio for HPLC and LCMS, underscoring how sustainability is reshaping both science and business. These solvents-including ethanol, methanol and acetonitrile-are designed to reduce reliance on fossil-based materials and lower environmental footprints, all without...

Read more

Apta Health Helps Employers Expose Hidden Fees and Inefficiencies in Medical and Rx Spending as Healthcare Costs Continue to Rise

June 23, 2026 10:00 AM

After two years of building and refining its market check technology, Apta Health is bringing new visibility to its Medical and Rx Market Checks through Apta Connect. Apta Connect is Apta Health's proprietary software platform that reviews a group's medical and pharmacy claims, compares them to industry data sets, and shows where the plan may be overpaying or missing lower cost opportunities. Many employers have historically treated their health...

Read more

Revecore Launches ReClaim(TM), an AI-Native Platform Built for the Complexity Modern Hospitals Face

June 23, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced the launch of Revecore ReClaim™, an AI-powered revenue recovery intelligence platform and the technology foundation behind every Revecore service. ReClaim builds on the AI-driven underpayment recovery and clinical appeals capabilities announced in April. The platform extends that investment into a unified, AI-native...

Read more

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

June 23, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that the company has completed submission of its New Animal Drug Application (NADA) to the U.S. Food and Drug Administration's Center for Veterinary Medicine for full approval of crofelemer for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Crofelemer, under the name Canalevia®-CA1, is currently conditionally approved for this indication in dogs. "We're very happy to...

Read more

AGS Health Expands Leadership Team, Deepening Its Commitment to RCM AI Innovation and Strategic Growth

June 23, 2026 9:00 AM

In a reflection of its accelerating investment in AI, automation, data management, and company growth, AGS Health® today announced the expansion of its executive leadership team. These appointments underscore the company's commitment to delivering on the promise of revenue cycle AI through practical innovation, clinical expertise, and ROI-driven solutions. As a provider of tech-enabled revenue cycle management (RCM) solutions and a strategic...

Read more

CVS Health: Thank You! Mews at St. Mary Grand Opening - Williamstown, NJ

June 23, 2026 9:00 AM

Last week, we proudly celebrated the Grand Opening and Building Dedication of Mews at St. Mary in Williamstown, NJ, alongside our amazing colleagues, local leaders, community organizations, development partners, and The Bishop of Camden. Mews at St. Mary is now home to 75 affordable homes for seniors, thoughtfully designed to encourage community, friendship, and support for our aging population. Developed by The Diocese of Camden and The Walters...

Read more

TRNR CEO to Participate in Fireside Chat at Maxim Group's Health, Wellness & Longevity Conference on July 22, 2026

June 23, 2026 8:30 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced that Co-Founder and Chief Executive Officer Trent Ward has been invited to participate in a fireside chat at Maxim Group's Health, Wellness & Longevity Conference on Wednesday, July 22, 2026. The session will be a one-on-one discussion moderated by Thomas Forte,...

Read more

Stemtech Corporation Issues 2025 Year-In-Review Letter Highlighting Corporate Strength, Global Expansion and Accelerating Market Opportunities

June 23, 2026 8:30 AM

Stemtech Corporation (OTCID:STEK), a The Pioneer and global leader in stem cell nutrition and plant-based wellness solutions, today issued a joint letter to shareholders from Chairman and Chief Executive Officer Charles S. Arnold and President and Chief Operating Officer John W. Meyer, outlining the Company's strategic progress in 2025 and the initiatives positioning the Company for growth in 2026 and beyond. To Our Shareholders: 2025 was a year...

Read more

Renowned Life Science Leader Dr. Gino Martini Joins KIFFIK Biomedical as Chief Scientific Officer

June 23, 2026 8:00 AM

KIFFIK Biomedical today announced that Luigi (Gino) Martini, Ph.D., FRPharmS, MBA, has been appointed Chief Scientific Officer (CSO). Dr. Martini's career spans senior leadership roles across global pharmaceutical companies including GSK, Roche, Shire, and Catalent, as well as academic appointments at King's College London and policy leadership at the Royal Pharmaceutical Society. His work has focused on oncology, rare diseases, precision...

Read more

LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System

June 23, 2026 7:00 AM

LEM Surgical Inc., a pioneer in advanced robotic technologies for hard tissue surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted an additional 510(k) clearance for its Dynamis Robotic Surgical System. This landmark milestone introduces further capabilities to the groundbreaking, surgical humanoid architecture that is focused on the global orthopedic and spine surgery market. The Dynamis Robotic Surgical System...

Read more